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A syndrome associating Livedo Reticularis (LR) with Cerebrovascular
disease (CVD) was described, in 1965, by Sneddon. It occurs sporadi-
cally, but a few familial cases of Sneddon’s Syndrome (SS) have been
reported, like these 3 cases that represent one of the largest number
among siblings. We studied three male brothers, aged 28, 37 and
42 years, with CVD (ischaemic stroke in 2 patients and cerebral
haemorrhages in the third) and their sister with no CVD. All patients
presented with long lasting Livedo Reticularis, extending beyond the
lower limbs. Skin biopsy on the centre of the reticular pattern showed,
only in the second patient, partial endothelium detachment in dermo-
hypodermic blood vessels. The males also had accesses of Livedoid
Vasculitis (LV), in which a skin biopsy showed obliteration of several
upper dermal vessels with hialin thrombi and a very scarce inflamma-
tory infiltrate. Complementary studies, with an extensive investigation
on pro-coagulation/pro-thrombotic features including antiphospholipid
antibodies, were repeatedly negative. Their non-consanguineous par-
ents were not affected, but among these kindred of 9 individuals, apart
from the 4 patients reported above, LR and LV were present in two
other brothers and also in an aunt and uncle, suggesting autosomal
dominant pattern of inheritance, with incomplete penetrance. The
relationship between Sneddon’s Syndrome and Antiphospholipid Anti-
body Syndrome is controversial. The present cases, having repeatedly
negative antiphospholipid antibodies, support the classification of
Sneddon’s Syndrome as an independent nosological entity.
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T he association of Livedo Reticularis (LR) andcerebrovascular disease (CVD), occurring in theabsence of any predisposing disease, was first
described, in 1965, by Sneddon, in 6 patients, 5 of whom
were women [1]. This association was further reported in
more than 100 cases and is now known as Sneddon’s
syndrome [2-31]. It occurs sporadically, but some familial
cases have been reported [2-7]. We had the opportunity to
study four members of a kindred of 9 individuals all with
exuberant LR, 3 of whom also had CVD.
Case Reports
Patient 1 – A 28-year-old male, with a personal history of
mild hypertension, was hospitalised at the Neurology
Department, in January 2000, with sudden weakness of
the upper and lower right limbs due to a left ischaemic
stroke. Imaging data revealed infarcted areas on MRI
(Fig. 1). A CT scan and a cerebral angiography were
normal.
Patient 2 – A 42-year-old male, also with a personal
history of mild hypertension, was admitted to the Neurol-
ogy Department, in February 2000, with a sudden weak-
ness in the left limbs due to a right ischaemic stroke.
Complementary imaging data showed infarcted areas on
CT scan and MRI; cerebral angiography was normal.
Patient 3 – A 38-year-old male was hospitalised at the
Neurology Department, in November 2001, for re-
examination after the occurrence of 2 intracerebral haem-
orrhages (age 23 and 34). He also had mild hypertension.
Complementary imaging examination, performed then,
revealed haemorrhagic areas on a CT scan and haemor-
rhagic sequellae on MRI; angiography was normal.
Patient 4 – A 32-year-old female sister, with no sponta-
neous fetal deaths, no use of oral contraceptives and no
systemic hypertension, was also studied in November
2001. She had no history of cerebrovascular events and
imaging data of the central nervous system showed no
alterations.
None of them had a history of smoking.
Dermatological examination showed, in all patients, per-
sistent violaceous Livedo Reticularis (Fig. 2), with a large,
asymmetric, open reticular pattern, localised mainly in the
lower limbs and buttocks, extending to the trunk and
upper limbs in the 3 male patients. LR began between the
ages of 13 and 18 and slowly progressed thereafter, being
most striking in the third patient, whose LR began at an
earlier age. Histology of a scalpel skin biopsy performed
in the centre of the reticular pattern and deep into the
Eur J Dermatol 2003; 13: 283–7
EJD, vol. 13, n° 3, May–June 2003 283
adipose tissue revealed abnormalities only in the second
patient: partial endothelium detachment in dermo-
hypodermic blood vessels with no inflammatory infiltrate
(Fig. 3) .
In the lower legs, the three male brothers also had
brownish and purpuric macules with atrophic porcelanic
scars resulting from seasonal ulceration (Fig. 4). A skin
biopsy performed in patient 1, in a recent necrotic lesion
of the lower leg, showed hialin thrombi obliterating
several upper dermal vessels, with a very scarce inflam-
matory infiltrate.
Direct immunofluorescence in normal skin was negative
in all patients.
The study for cerebral stroke occurring in youth, per-
formed at least twice in each patient, more than 6 months
apart, was normal or negative. It included complete blood
cell count, blood chemistry, erythrocyte sedimentation
rate, lipid profile, serum protein electrophoresis, cryoglo-
bulins, circulating immune complexes, coagulation stud-
ies, pro-thrombotic factors (antithrombin III, anti-
plasmine, fibrin degradation products, fibrinogen, lupus
anticoagulant, C and S protein, prothrombine mutation,
Factor V of Leiden, Factors II, V, VII, VIII (C/AG), IX C,
X, XII, Homocysteine, MTHFR / GA 20210 II), comple-
ment fractions (C3, C4), rheumatoid factor, VDRL, anti-
nuclear antibodies (ANA), antineutrophil cytoplasm anti-
bodies (ANCA), anticardiolipine antibodies (IgG, IgM),
anti-2GPI antibodies (IgG, IgM), antiphospholipid anti-
bodies (IgG, IgM). Serology for HIV 1 and 2, ECG,
echocardiography and carotid duplex sonography, was
normal or negative.
As patients refused treatment with warfarine, they are all
under treatment with an antiplatelet agent (acetylsalicylic
Figure 1. MRI in patient 1, showing infarcted areas.
Figure 2. Livedo reticularis also affecting the trunk, in pa-
tient 2.
Figure 3. Histology of LR in patient 2: a detail showing
partial endothelium detachment (H and E).
Figure 4. Atrophic scars resulting from seasonal accesses of
livedoid vasculitis in patient 2.
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acid, 150 mg, daily), associated with antithrombotic
therapy (dipyridamole, 150 mg, twice a day) in the male
patients. Under therapy, in August 2000, patient 2 suffered
a new cerebrovascular stroke, with neuro-ophthalmic
signs (internuclear ophthalmoplegia) which completely
resolved. Patients 1 and 2 maintain hemiparesia minor and
patient 3 has important sequellae with right hemiparesia
and disphasia. Patient 4 remains with no CVD, after
16 months.
Family history
Their non-consanguineous parents are healthy but an aunt
and an uncle had LR and LV. Within these kindred with
6 sons and 3 daughters, 6 have LR, 3 of them with no
cerebrovascular events (Table I).
Discussion
The association of LV and CVD occurring in 3 of our
patients without any predisposing factor is the hallmark of
Sneddon’s Syndrome.
Sneddon described strokes, usually of limited extension,
frequently with minor residual sequellae, that occur at a
young age and may further repeat [1, 2]. Nevertheless in
other reported cases of SS the CVD was haemorrhagic
[28-31]. The 3 patients reported suffered the 1st cere-
brovascular accident between the ages 23 and 42 years,
and patients 2 and 3 had a 2nd cerebrovascular accident.
CVD in patient 1 and 2 was thrombotic whereas patient
3 had intracerebral hemorrhages.
LR in SS begins also in youth, suffers progressive
evolution, usually extending beyond the lower limbs and
typically shows an open and irregular lattice pattern [1, 2].
It is the first symptom in the majority of patients,
preceding CVD for many years, as occurred in these
patients whose skin lesions preceded cerebrovascular
events for 9 to 26 years [1,2]. The occurrence of livedoid
vasculitis (LV) with seasonal ulcerations, as in our pa-
tients, was also described in four cases [16].
The histopathologic hallmark of LR in SS is an endothe-
litis and endarteritis obliterans [32, 33]. The single patient
of these 4 who had alterations on skin histology showed











Table I. Pedigree suggesting a dominant autosomal transmission with incomplete penetrance and variable expressivity
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according to Zelger et al., as the initial phase of this
disease (Stage I) [33].
The complementary study was repeatedly normal or
negative for pro-coagulant and pro-thrombotic risk fac-
tors, including the search for antiphospholipid antibodies
(anticardiolipin, anti-beta2-GPI, both IgG and IgM).
Like in the first cases presented by Sneddon [1] and
among the 153 cases later published as SS, women were
affected in 71.24% (44 men, 109 women) [3, 5-31], but in
this kindred only 3 males have developed SS, as in other
reported cases [5, 10, 11, 14, 21, 28, 31].
In the first cases reported by Sneddon and Rebollo no
studies for antiphospholipid antibodies were performed
[1,2], but among the 153 patients published thereafter,
seventy five – 49% (22 men, 53 women) – had positive
anti-phospholipidic antibodies [5, 15-27], whereas sev-
enty eight – 51% (22 men, 56 women) - presented nega-
tive antiphospholipid antibodies [3, 6-18, 20-24, 27-31].
Antiphospholipid Antibody Syndrome (APS) is an ac-
quired multisystem disorder of hypercoagulation, occur-
ring either secondary to LES and other autoimmune
diseases or as a primary disease. Serologic markers are:
lupus anticoagulant and anticardiolipin antibodies, usually
associated with mild thrombocythopenia and abnormal
partial thromboplastin time. Clinical features include:
recurrent thrombotic events and repeated fetal loss. Cuta-
neous manifestations may occur and include LR, as in
Sneddon’s Syndrome. Nevertheless, noninflammatory
vascular thrombosis is the most frequent histopathologic
feature in APS [32], whereas in SS endothelitis and
endarteritis obliterans are more characteristic [32, 33].
Although there are overlapping manifestations between
SS and APS, namely LR and recurrent thrombotic events,
their relationship remains controversial [15-27]. In our
cases, repeatedly negative antiphospholipid antibodies as
well as the absence of thrombocytopenia and abnormal
partial thromboplastin time support the classification of
SS as a rare but well-defined independent nosological
entity, which is also in agreement with the opinions of
Rehany and Zelger et al. [7, 8, 33].
There are other syndromes associating neurological and
cutaneous alterations of vascular origin, where precocious
cutaneous lesions may allow a correct diagnosis and the
institution of early therapy, eventually preventing neuro-
logical sequellae [34]. Divry Van Bogaert’s syndrome
(DVB) is one of these rare entities that has to be
distinguished from SS [34]. Described by a neurologist, in
1946, DVB is characterised by recurrent strokes in young
patients preceded by LR localized mainly on the face and
distal extremities. Skin biopsies show no vasculitis, but an
increased number of dermal vessels with smooth muscles
fibers disposed around them. CT scan and MRI can be
identical to SS but cerebral angiography showing corti-
comeningeal angiomatosis with collateral vascular anas-
tomosis and narrow and helicine vessels in the midcere-
bral artheries, is diagnostic of DVB [34, 35]. Normal
cerebral angiography in our patients does not support this
diagnosis.
Most cases of Sneddon’s Syndrome are sporadic, but there
are also some rare familial cases reported [2-7]. In 1983
Rebollo et al. described three families, in 1986 Scott et al.
reported a sister and a brother of another family, in 1994
Pettee et al described SS in two brothers, in 1995 Lossos
et al. reported another family and, in 1998, Rehany et al.
described two siblings from one family. The inheritance
pattern was variable: autosomal dominant transmission for
the families of Rebollo [2], Scott [3] and Lossos [6] and
autosomal recessive transmission for the cases of Pettee
[5] and Rehany [7]. The present report represents one of
the largest number among siblings ever described and
suggests a dominant autosomal transmission with incom-
plete penetrance and variable expressivity. j
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